Original Research
Published on 17 Sep 2021
Dipeptidyl Peptidase 4 Inhibitors Decrease the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Infection and Type 2 Diabetes Mellitus: A Nationwide Study in Taiwan
in Clinical Diabetes
- 4,536 views
- 41 citations













